This is a synthetic peptide designed for use in combination with anti-FANCA antibody (Catalog #: ARP41678_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
FANCA
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
FANCA
(Fanconi Anemia Group A Protein (FANCA))
Synonyme
FA Peptide, FA-H Peptide, FA1 Peptide, FAA Peptide, FACA Peptide, FAH Peptide, FANCH Peptide, AW208693 Peptide, Fanconi anemia complementation group A Peptide, Fanconi anemia, complementation group A Peptide, FANCA Peptide, Fanca Peptide
Hintergrund
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FAN
Alias Symbols: FA, FA-H, FA1, FAA, FACA, FAH, FANCH, MGC75158
Protein Interaction Partner: BRCA1,FANCA,FANCG,AKT1,BRCA1,CDK1,FANCA,FANCC,FANCE,FANCF,FANCG,HES1,IKBKB,SMARCA4,SMARCC1,SMARCD3,SNX5,SPTAN1,AKT1,ALDOA,ATP5B,AZIN1,BAT1,BLM,BRCA1,C17orf70,C19orf40,CCT3,CD79A,CDK1,CHUK,DAXX,DNAJB1,DUS4L,ENO1,ERCC4,FANCA,FANCB,FANCC,FANCE,FANCF,FANCG,FANCL,FANCM,GNB2,HPRT1,HSP90AA1,HSP90B1,IFIT3,IKBKB,KRT1,LIPG,MKNK1,MX1,NAMPT,NUB1,PRPF31,PSMA5,RMI1,RPA1,RPL18,SGK1,SMARCA4,SNX5,SPTA1,SPTAN1,TAF10,TCERG1,TCP1,TOP3A,TPT1,YDL160C-A,YOL086W-A,ZNF24